Literature DB >> 20627336

Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia.

Sungsoo Lee1, Chien-Sheng Huang, Tomohiro Kawamura, Norihisa Shigemura, Donna B Stolz, Timothy R Billiar, James D Luketich, Atsunori Nakao, Yoshiya Toyoda.   

Abstract

BACKGROUND: Increasing allograft ischemic time is a significant risk factor for mortality following heart transplantation (HTx). The purpose of this study was to evaluate the protective effects of histidine-tryptophan-ketoglutarate (HTK) and Celsior (CEL) using a rat HTx model with prolonged cold storage.
METHODS: The hearts were excised from donor rats, stored in cold preservation solution for either 6 or 18 hours, and heterotopically transplanted into syngeneic recipients. Serum creatine phosphokinase (CPK), serum troponin I, graft-infiltrating cells, graft mRNA levels for inflammatory mediators, and tissue adenosine triphosphate (ATP) levels were analyzed, as markers of graft injury.
RESULTS: The recipients of grafts stored in HTK for 18 hours of prolonged cold ischemia had lower levels of serum CPK and tissue malondialdehyde, less upregulation of the mRNAs for IL-6 and inducible nitric oxide synthase, less apoptosis, and higher ATP levels than those receiving grafts stored in CEL and Saline. Cardiac contraction 3 hours after reperfusion was observed in 43% of the cardiac grafts stored in HTK for 18 hours, while no cardiac wall movement was seen in grafts stored in either saline or CEL.
CONCLUSION: Cold storage in HTK exhibited superior protective effects against prolonged cold ischemia in a syngeneic rat transplantation model. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20627336     DOI: 10.1016/j.surg.2010.04.009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

Review 1.  Custodiol for myocardial protection and preservation: a systematic review.

Authors:  J James B Edelman; Michael Seco; Ben Dunne; Shannon J Matzelle; Michelle Murphy; Pragnesh Joshi; Tristan D Yan; Michael K Wilson; Paul G Bannon; Michael P Vallely; Jurgen Passage
Journal:  Ann Cardiothorac Surg       Date:  2013-11

2.  Lidocaine and Pinacidil Added to Blood versus Crystalloid Cardioplegic Solutions: Study in Isolated Hearts.

Authors:  Helison Pereira do Carmo; Karla Reichert; Daniela Diógenes de Carvalho; Lindemberg da Mota Silveira-Filho; Karlos Vilarinho; Pedro Oliveira; Orlando Petrucci
Journal:  Braz J Cardiovasc Surg       Date:  2018 May-Jun

3.  Comparison of fractal dimension and Shannon entropy in myocytes from rats treated with histidine-tryptophan-glutamate and histidine-tryptophan cetoglutarate.

Authors:  Marcos Aurélio Barboza de Oliveira; Antônio Carlos Brandi; Carlos Alberto dos Santos; Paulo Henrique Husseni Botelho; José Luís Lasso Cortez; Moacir Fernandes de Godoy; Domingo Marcolino Braile
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Apr-Jun

4.  Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH.

Authors:  Jindong Li; Yanhong Wu; Xudong Tian; Jiantang Wang; Mingfeng Dong; Anbiao Wang; Shengjun Ma
Journal:  Biosci Rep       Date:  2017-12-07       Impact factor: 3.840

5.  Perturbations in cardiac metabolism in a human model of acute myocardial ischaemia.

Authors:  Sanoj Chacko; Mamas A Mamas; Magdi El-Omar; David Simon; Sohaib Haseeb; Farzin Fath-Ordoubadi; Bernard Clarke; Ludwig Neyses; Warwick B Dunn
Journal:  Metabolomics       Date:  2021-08-23       Impact factor: 4.290

6.  Comparison of the solution of histidine-tryptophan-alfacetoglutarate with histidine-tryptophan-glutamate as cardioplegic agents in isolated rat hearts: an immunohistochemical study.

Authors:  Marcos Aurélio Barboza de Oliveira; Lívia Carvalho Ferreira; Débora Aparecida Pires de Campos Zuccari; Antônio Carlos Brandi; Carlos Alberto dos Santos; Paulo Henrique Husseni Botelho; Orlando Petrucci; Domingo Marcolino Braile
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.